Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tannenbaum

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1996
Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levelsM T Landi, C Zocchetti, I Bernucci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathwaysTanya Das, Gaurisankar Sa, Ewa Paszkiewicz-Kozik, et al.
Oncoimmunology|April 17, 2023
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppressionPaul G Pavicic, Patricia A Rayman, Shadi Swaidani, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|October 9, 2015
Measurement of Resource Utilization for Total and Reverse Shoulder ArthroplastyRichard S Tannenbaum, Ronald Navarro, Nazeem Virani, et al.
Cancer Research|July 5, 2006
GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunctionKaushik Biswas, Amy Richmond, Patricia Rayman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomasMark V Thornton, Daisuke Kudo, Patricia Rayman, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|January 12, 2026
Quality improvement initiative to optimize use of rapid genomic sequencing in a level IV NICUAlissa M D'Gama, Rachel S Hu, Maya C Del Rosario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinomaR M Bukowski, P Rayman, L Molto, et al.
Cancer Medicine|November 17, 2018
Surgeon peer network characteristics and adoption of new imaging techniques in breast cancer: A study of perioperative MRISara S Tannenbaum, Pamela R Soulos, Jeph Herrin, et al.
Cancer Immunology Research|August 24, 2019
Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCsCharles S Tannenbaum, Patricia A Rayman, Paul G Pavicic, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1996
Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levelsM T Landi, C Zocchetti, I Bernucci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathwaysTanya Das, Gaurisankar Sa, Ewa Paszkiewicz-Kozik, et al.
Oncoimmunology|April 17, 2023
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppressionPaul G Pavicic, Patricia A Rayman, Shadi Swaidani, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|October 9, 2015
Measurement of Resource Utilization for Total and Reverse Shoulder ArthroplastyRichard S Tannenbaum, Ronald Navarro, Nazeem Virani, et al.
Cancer Research|July 5, 2006
GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunctionKaushik Biswas, Amy Richmond, Patricia Rayman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomasMark V Thornton, Daisuke Kudo, Patricia Rayman, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|January 12, 2026
Quality improvement initiative to optimize use of rapid genomic sequencing in a level IV NICUAlissa M D'Gama, Rachel S Hu, Maya C Del Rosario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinomaR M Bukowski, P Rayman, L Molto, et al.
Cancer Medicine|November 17, 2018
Surgeon peer network characteristics and adoption of new imaging techniques in breast cancer: A study of perioperative MRISara S Tannenbaum, Pamela R Soulos, Jeph Herrin, et al.
Cancer Immunology Research|August 24, 2019
Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCsCharles S Tannenbaum, Patricia A Rayman, Paul G Pavicic, et al.
Pageof 19